| Description |
1 online resource (140 p.) |
| Contents |
Cover -- Half Title -- Title Page -- Copyright Page -- Dedication -- Table of Contents -- Preface -- Authors -- 1 Introduction to Coronaviruses and COVID-19 -- 1.1 Introduction -- 1.2 Coronavirus: Definition, History, and Classification -- 1.3 Behavior of Viruses -- 1.4 Origin of the Novel Coronavirus (nCoV-19) -- 1.5 Nomenclature of Novel Coronavirus (nCoV-19) andthe Disease -- 1.6 Symptoms of COVID-19 -- 1.7 Transmission of COVID-19 -- References -- 2 Biology of Coronaviruses with Special Reference to SARS-CoV-2 -- 2.1 Introduction -- 2.2 SARS-CoV-2 Structure and Function |
|
2.2.1 Basic Structure of SARS-CoV-2 -- 2.2.1.1 Spike Protein -- 2.2.1.2 Membrane Protein -- 2.2.1.3 Envelope Protein -- 2.2.1.4 Viral Envelope -- 2.2.1.5 Viral Capsid -- 2.2.1.6 Nucleocapsid Protein -- 2.2.2 Basic Structure of Genetic Material of SARS-CoV-2 -- 2.2.2.1 Spike Protein Gene -- 2.2.2.2 Envelope Protein Gene -- 2.2.2.3 Membrane Protein Gene -- 2.2.2.4 Nucleocapsid Protein Gene -- 2.3 Lifecycle of SARS-CoV-2 -- 2.3.1 Attachment and Entry -- 2.3.2 Replication and Transcription of Viral Genetic Material -- 2.3.3 Assembly and Release of Viral Particle -- 2.4 Pathophysiology |
|
2.4.1 Pneumonia to Acute Respiratory Distress Syndrome: Underlying Cause -- 2.4.2 Cough with Mucus in Patients with ARDS: Consolidation -- 2.4.3 Reason behind High Body Temperature (Pyrexia), Increased Heart Rate (Tachycardia), and Increased Respiratory Rate (Tachypnea) -- 2.4.4 Reason behind Septic Shock and Multisystem Organ Failure (MSOF) -- References -- 3 Epidemiology, Pharmacology, Diagnosis, and Treatment of COVID-19 -- 3.1 Introduction -- 3.2 Epidemiology of COVID-19 -- 3.2.1 Case Fatality Rate -- 3.2.2 Basic Reproduction Number (R[sub(0)]) -- 3.2.3 Serial Interval |
|
3.3 Pharmacology of COVID-19 -- 3.3.1 Designing of Interventions Based on Receptor-Binding Processes -- 3.3.2 Designing of Interventions Based on Uncoating, Replication, and Translation of Viral Genetic Material -- 3.3.3 Designing of Interventions Based on the Synthesis of Structural Proteins and Assembly of Viral Particles -- 3.4 Diagnosis of COVID-19 -- 3.5 Conventional Treatment of COVID-19 -- 3.5.1 Investigational Antiviral Agents -- 3.5.2 Immunomodulators and Other Investigational Therapies -- References -- 4 COVID-19 Precautions and Management Strategies -- 4.1 Introduction |
|
4.2 Maintaining Proper Hand Hygiene -- 4.3 Maintaining Proper Respiratory Etiquette -- 4.4 Cleaning and Disinfection of Surfaces in Nonhealthcare Settings -- 4.5 Maintaining Proper Self-Isolation and Quarantine and Seeking Medical Care -- References -- 5 Cutting-Edge Research to Combat COVID-19 -- 5.1 Introduction -- 5.2 Research and Development of Vaccines -- 5.3 Research and Development of Antibody-Directed Therapies -- 5.4 Investigational Immunotherapies Associated with COVID-19 -- 5.5 Investigational Devices Associated with COVID-19 -- References |
| Notes |
Description based upon print version of record |
|
6 Public Health Concerns and Issues Regarding COVID-19 |
| Subject |
COVID-19 (Disease)
|
|
COVID-19 (Disease) -- Environmental aspects
|
|
COVID-19
|
|
COVID-19 (Disease)
|
|
COVID-19 (Disease) -- Environmental aspects
|
| Form |
Electronic book
|
| Author |
Goswami, Srijan
|
|
Mitra, Abhijit
|
| ISBN |
9781000327595 |
|
1000327590 |
|
